期刊文献+

替勃龙治疗对绝经后妇女乳腺及子宫内膜的影响 被引量:2

下载PDF
导出
摘要 目的探讨替勃龙治疗围绝经期综合症对绝经后妇女乳腺及子宫内膜的影响。方法选择120例绝经后有围绝经期综合征症状的妇女分为2组,A组64例,给予替勃龙2.5mg,每日1次;B组56例,口服结合雌激素0.625mg和甲羟孕酮2.5mg,每晚一次。均连续服用一年。观察2组治疗前、后Greene评分、乳房胀痛情况、双侧乳腺致密度评分、子宫内膜厚度等的变化。结果治疗前后双侧乳腺致密度评分差异A组无统计学意义(P>0.05),B组有统计学意义(P<0.05);两组治疗前、后阴超检查子宫内膜厚度,差异均无统计学意义(P<0.05);2组治疗前、后Greene评分差异均有统计学意义(P<0.05)。结论替勃龙治疗绝经后围绝经期综合征妇女时不会发生乳腺结构改变及子宫内膜病变。
作者 万利群 李凌
出处 《中国医药指南》 2012年第36期247-249,共3页 Guide of China Medicine
  • 相关文献

参考文献5

二级参考文献11

  • 1康佳丽,王小霞,夏薇.替勃龙用于绝经后妇女乳腺增生的临床观察[J].中国妇幼健康研究,2006,17(2):86-88. 被引量:2
  • 2曹泽毅.中华妇产科学(下册)[M].北京:人民卫生出版社,2004.2091.
  • 3O’Connor IF,Shembekar MV,Shousha S.Breast carcinoma developing in patients on hormone replacement therapy: a histological and immunohistological study[].Journal of Clinical Pathology.1998
  • 4Hulka BS,Moorman PG.Breast cancer: hormones and other risk factors[].Maturitas.2001
  • 5Marttunen MB,Hietanen P,Pyrh nen S,et al.A prospective study on women with a history of breast cancer and with or without estrogen replacement therapy[].Maturitas.2001
  • 6Dupont WD,Page DL,Parl FF,et al.Estrogen replacement therapy in women with a history of proliferative breast disease[].Cancer.1999
  • 7Delgado RC,Lubian Lopez DM.Prognosis of breast cnacers detected in women receiving hormone replacement therapy[].Maturitas.2001
  • 8Bassett LW.Imaging of breast masses[].Radiologic Clinics of North America.2000
  • 9Verheul HAM,Coelingh-Bennink HJT,Kenemans P,et al.Effects of estrogens and hormone replacement therapy on breast cancer risk and on efficacy of breast cancer therapies[].Maturitas.2000
  • 10Beckmann MW,Jap D,Djahansouzi S,et al.Hormone replacement therapy after treatment of breast cancer: effects on postmenopausal symptoms, bone mineral density and recurrence rates[].Oncology.2001

共引文献19

同被引文献33

  • 1徐苓,赵珩,葛秦生.围绝经期的流行病学调查[J].生殖医学杂志,1993,2(1):23-27. 被引量:105
  • 2莎仁高娃,姜颖,姜玉新,林守清,孙爱军,王亚平.超声监测激素治疗对中老年妇女乳腺的影响[J].中国临床医学影像杂志,2010,21(11):770-773. 被引量:5
  • 3赵健.子宫内膜细胞学诊断系统[J].中国生育健康杂志,2006,17(1):6-8. 被引量:64
  • 4连利娟,林巧稚主编.妇科肿瘤学(M).第4版,北京:人民卫生出版社,2006:420.
  • 5ASIA-PACIFIC MENOPAUSE FEDERATION. Consensus Statement on the Management of the Menopause[M].Vietnam:APMF,2008.
  • 6PIRHONEN JP,VUENTO MH,MAKINEN JI. Long-timeeffects of hormone replacement therapy on the uterus and uterine circulation[J].{H}AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,1993,(02):620-630.
  • 7TAKAHASHI K,YOSHINO K,EDA Y. Prevalence of polycystic ovaries by transvaginal ultrasound and serum androgens[J].{H}International Journal of Fertility,1992,(05):290-294.
  • 8LI Y,YU Q,MA LK. Prevalence of depression and anxiety symptoms and their influence factors during menopausal transition and postmenopause in Beijing city[J].{H}MATURITAS,2008,(03):238-242.
  • 9MICHAEL R,SOULES SS,ESTELLA P. Executive summary:stages of reproductive aging workshop (STRAW)[J].{H}Fertility and Sterility,2001,(05):874-878.
  • 10TABOE A,WATT HC,WALD NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding[J].{H}OBSTETRICS AND GYNECOLOGY,2002,(04):663-670.

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部